Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: A population pharmacokinetic study

Iris Dotan*, Yulia Ron, Henit Yanai, Stuart Becker, Sigal Fishman, Lior Yahav, Merav Ben Yehoyada, Diane R. Mould

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

240 Scopus citations

Fingerprint

Dive into the research topics of 'Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: A population pharmacokinetic study'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology